Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Jade Biochemistry Pharmacy is a prominent Chinese pharmaceutical company specializing in the large-scale production of Active Pharmaceutical Ingredients (APIs), particularly within the lincosamide antibiotic class. The company is recognized as one of the world's largest manufacturing bases for Lincomycin Hydrochloride and its derivatives, including Clindamycin Hydrochloride and Clindamycin Phosphate. As a core subsidiary of the Guobang Pharmaceutical Group, it operates advanced manufacturing facilities that adhere to international quality standards, including US FDA and European GMP certifications. Their products are distributed globally, serving as critical components for the pharmaceutical industry in the treatment of various bacterial infections. The company leverages integrated fermentation and chemical synthesis technologies to maintain a leading position in the global antibiotic supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Jade Biochemistry Pharmacy.